Medical Condition News

RSS

BHGI's approach to cancer treatment guidelines for low- and moderate-income countries

When the prestigious British medical journal The Lancet Oncology this week published six cancer treatment guideline papers aimed at the resource-diverse nations of Asia, it used as its model the economic template developed by the Breast Health Global Initiative (BHGI) based at Fred Hutchinson Cancer Research Center.

31 Oct 2009

FDA approves an expanded indication for BYETTA injection

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.

31 Oct 2009

Data from multiple clinical and preclinical studies evaluating Hematide announced

Affymax, Inc. and Takeda Pharmaceutical Global Research & Development Center, Inc., today announced data from multiple clinical and preclinical studies evaluating Hematide, including preliminary results of a Phase 2 trial which demonstrated that Hematide increased hemoglobin levels in a group of anemic hemodialysis (HD) patients.

31 Oct 2009

Solasia Pharma completes Phase I clinical trial for Sancuso extended release transdermal granisetron patch

Solasia Pharma K.K. (http://www.solasia.co.jp), a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today the completion of a Phase I clinical trial for SP-01 (extended release transdermal granisetron patch; brand name: Sancuso®) in Japanese volunteers.

30 Oct 2009

Hyperthermia therapy delivered through BSD Medical's system improves survival rate for bladder cancer patients

BSD Medical Corporation today announced that published study results demonstrated improvement in overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy, delivered using the BSD-2000 Hyperthermia System, to the standard treatment regimen for 45 patients with high-risk bladder cancer.

30 Oct 2009

NIH awards Charles Drew University $9.8M to reduce cancer health disparities in underserved populations

Charles Drew University has been awarded $9.8 million from three major national funders to support the university's long-term, UCLA partnership aimed at reducing the risk of cancer among minorities in poor and disadvantaged communities.

30 Oct 2009

Bayer HealthCare's Phase II study results of imaging agent florbetaben

Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at the 19th World Congress of Neurology (WCN).

30 Oct 2009

Cosmetic pesticides cause cancer, CCSBCY calls for government action

The Canadian Cancer Society B.C. and Yukon is calling on the provincial government to accelerate its plans and initiate a defined and timely public consultation on the use of cosmetic chemical pesticides to protect public health and the environment by the end of this year.

30 Oct 2009

VIA Pharmaceuticals to discuss its cardio-metabolic product portfolio at the Target 2009 conference

VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.

30 Oct 2009

Annual dilated eye exam helps prevent vision loss in people with diabetes

Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam.

30 Oct 2009

Cancer patients in northern Portugal to gain access to advanced cancer treatments

Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the Instituto Portugues Oncologia, IPO Porto.

30 Oct 2009

Tips for reducing neck and back injuries

With school underway, attention is focused on backpack safety. But carrying heavy bags, briefcases, computers, luggage and even handbags can affect anyone.

30 Oct 2009

Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial

Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.

30 Oct 2009

New social networking site for breast cancer survivors

Breast cancer activists, survivors and supporters now have their very own online Web community to share unique experiences and insights around breast cancer. Launching this week, the new social networking site “myKomen” centers on individual and shared experiences with a disease that will afflict 200,000 women and men this year alone.

30 Oct 2009

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Oncolytics Biotech Inc. announced that a poster presentation covering updated results of a Phase II study of REOLYSIN(R) administered intravenously to patients with sarcomas metastatic to the lung will be presented at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting being held in Miami Beach, Florida on November 6th, 2009.

30 Oct 2009

Siemens Hearing Instruments introduces new hearing solutions at the ADA 2009 Convention

Siemens Hearing Instruments, Inc., (www.usa.siemens.com/hearing) one of the largest manufacturers of hearing instruments in the world, today announced several new product models and enhancements at SPLASH: The Academy of Doctors of Audiology's (ADA) 2009 Convention held October 29-31, 2009, in Clearwater, Florida.

30 Oct 2009

ASTRO to host news briefings on top cancer research papers

The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.

30 Oct 2009

Participation in clinical trials may offer better prognosis for patients with chronic heart failure

Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the November European Journal of Heart Failure.

30 Oct 2009

Young medical school graduates more likely to recommend kidney transplantation for CKD patients

Compared with veteran doctors, recent medical school graduates are more likely to refer chronic kidney disease (CKD) patients for kidney transplantation before their patients require dialysis, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.

30 Oct 2009

GPC establishes grants to expand knowledge about probiotics

Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.

30 Oct 2009

Medical Condition News

BHGI's approach to cancer treatment guidelines for low- and moderate-income countries

FDA approves an expanded indication for BYETTA injection

Data from multiple clinical and preclinical studies evaluating Hematide announced

Solasia Pharma completes Phase I clinical trial for Sancuso extended release transdermal granisetron patch

Hyperthermia therapy delivered through BSD Medical's system improves survival rate for bladder cancer patients

NIH awards Charles Drew University $9.8M to reduce cancer health disparities in underserved populations

Bayer HealthCare's Phase II study results of imaging agent florbetaben

Cosmetic pesticides cause cancer, CCSBCY calls for government action

VIA Pharmaceuticals to discuss its cardio-metabolic product portfolio at the Target 2009 conference

Annual dilated eye exam helps prevent vision loss in people with diabetes

Cancer patients in northern Portugal to gain access to advanced cancer treatments

Tips for reducing neck and back injuries

Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial

New social networking site for breast cancer survivors

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Siemens Hearing Instruments introduces new hearing solutions at the ADA 2009 Convention

ASTRO to host news briefings on top cancer research papers

Participation in clinical trials may offer better prognosis for patients with chronic heart failure

Young medical school graduates more likely to recommend kidney transplantation for CKD patients

GPC establishes grants to expand knowledge about probiotics

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News